First Tracks Biotherapeutics, Inc. (TRAX) insider trading.
In Q3 2026, insiders at First Tracks Biotherapeutics, Inc. reported 3 non-derivative transactions on 11 Forms 3, 4 and 5: 0 open-market purchases and 1 sale worth $1.8M.
- Transactions
- 3
- Purchases (P)
- 0
- Sales (S)
- 1
- Net shares, P minus S
- -39,265
- Insiders
- 2
- Last filed
- 2026-09-17
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Ware J. Anthony | Director | 2 | 0 | 1 |
| Orwin John A | Director | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-15 | Orwin John A | M (A) | 1,300 | $0 | 17,995 | Form 4 |
| 2026-09-02 | Ware J. Anthony | M (A) | 39,265 | $5.74 | 54,925 | Form 4 |
| 2026-09-02 | Ware J. Anthony | S (D) | 39,265 | $44.78 | 15,660 | Form 4 |
Transaction codes in this quarter
Get TRAX insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=2091349&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · TRAX company page · First Tracks Biotherapeutics, Inc. on SEC.gov
Questions
Are insiders buying or selling First Tracks Biotherapeutics, Inc. (TRAX)?
In Q3 2026, insiders at First Tracks Biotherapeutics, Inc. reported 3 non-derivative transactions on 11 Forms 3, 4 and 5: 0 open-market purchases and 1 sale worth $1.8M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these First Tracks Biotherapeutics, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/trax.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.